UNSPSC 85408502: Diagnosis of chromosome inversion in normal individual

This classification denotes the group of activities that yields a diagnosis of Chromosome inversion in normal individual. Chromosome inversion in normal individualis listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code Q95. 1

UNSPSC 85408502 Diagnosis of chromosome inversion in normal individual is a Commodity code with nominal scope in genetic diagnostics, but recent state and local solicitations show no alignment with this narrow clinical laboratory classification. The three most recent opportunities tagged under this code span diagnostic imaging systems, special education contracted services, and temporary health professional staffing — none of which involve chromosome inversion diagnosis or genetic testing of any kind. The mismatch suggests either tagging error in the source records or that this Commodity code sees minimal or no legitimate procurement activity in state and local markets.

San Mateo Medical Center (San Mateo County, California) posted an RFP for a Picture Archiving and Communication System (PACS) with proposals due October 21, 2026, and Birdville Independent School District (Tarrant County, Texas) posted a competitive sealed proposal request for special education contracted services including speech language therapy, occupational therapy, and psychology services due the same date. Santa Clara County Health System (California) opened a non-exclusive qualified vendor pool for temporary health professional staffing across ancillary clinical categories including audiology, diagnostic imaging, and therapy services with a proposal deadline of October 7, 2026. None of these three solicitations involve genetic diagnostics or chromosome analysis. The code shows no credible recent activity in its stated scope, and business development focus under this Commodity should be minimal unless the source records are corrected to reflect actual genetic testing procurement.